Literature DB >> 2357844

Human monoclonal IgM with autoantibody activity against two gangliosides (GM1 and GD1b) in a patient with motor neuron syndrome.

M O Jauberteau1, N Gualde, J L Preud'Homme, M Rigaud, R Gil, J M Vallat, N Baumann.   

Abstract

Small amounts of oligoclonal immunoglobulins were detected by Western blotting in the serum from a patient with motor neuron syndrome. The prominent one, a monoclonal IgM lambda, reacted strongly with the gangliosides GM1 and GD1b and more weakly with asialo GM1, as shown by immunoenzymatic staining of thin-layer chromatograms of gangliosides, ELISA on purified glycolipid coats and immunoadsorption with purified GM1. Affinity-chromatography with purified GM1 resulted in the purification of monoclonal IgM lambda. This purified IgM and its Fab fragments showed the same pattern of reactivity with gangliosides as that observed with whole serum. Such monoclonal IgM could be responsible for motor neuron diseases in some patients with overt or barely detectable monoclonal gammopathies.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2357844      PMCID: PMC1535287          DOI: 10.1111/j.1365-2249.1990.tb05231.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  33 in total

1.  Structure of sulfated glucuronyl glycolipids in the nervous system reacting with HNK-1 antibody and some IgM paraproteins in neuropathy.

Authors:  D K Chou; A A Ilyas; J E Evans; C Costello; R H Quarles; F B Jungalwala
Journal:  J Biol Chem       Date:  1986-09-05       Impact factor: 5.157

2.  Motor dominant neuropathy and IgM paraproteinemia: the IgM M-protein binds to specific gangliosides.

Authors:  S Kusunoki; T Shimizu; K Matsumura; K Maemura; T Mannen
Journal:  J Neuroimmunol       Date:  1989-02       Impact factor: 3.478

3.  A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside.

Authors:  A Pestronk; D R Cornblath; A A Ilyas; H Baba; R H Quarles; J W Griffin; K Alderson; R N Adams
Journal:  Ann Neurol       Date:  1988-07       Impact factor: 10.422

4.  [Study of antiglycolipid antibodies in IgM monoclonal dysglobulinemias associated with peripheral neuropathy].

Authors:  M O Jauberteau; D Henin; P Bouche; J M Vallat; M Dumas; S Dellagi; J M Leger; M L Harpin; H Ratinahirana; M P Chaunu
Journal:  Rev Neurol (Paris)       Date:  1988       Impact factor: 2.607

5.  An immune-mediated guinea pig model for lower motor neuron disease.

Authors:  J Engelhardt; F Joo
Journal:  J Neuroimmunol       Date:  1986-10       Impact factor: 3.478

6.  Serum antibodies to GM1 ganglioside in amyotrophic lateral sclerosis.

Authors:  A Pestronk; R N Adams; L Clawson; D Cornblath; R W Kuncl; D Griffin; D B Drachman
Journal:  Neurology       Date:  1988-09       Impact factor: 9.910

7.  Monoclonal IgM with unique specificity to gangliosides GM1 and GD1b and to lacto-N-tetraose associated with human motor neuron disease.

Authors:  N Latov; A P Hays; P D Donofrio; J Liao; H Ito; S McGinnis; M Konstadoulakis; L Freddo; M E Shy; K Manoussos
Journal:  Neurology       Date:  1988-05       Impact factor: 9.910

8.  Plasmapheresis alleviates neuropathy accompanying IgM anti-myelin-associated glycoprotein paraproteinemia.

Authors:  D C Haas; A H Tatum
Journal:  Ann Neurol       Date:  1988-04       Impact factor: 10.422

9.  Monoclonal IgM in two patients with motor neuron disease bind to the carbohydrate antigens Gal(beta 1-3)GalNAc and Gal(beta 1-3)GlcNAc.

Authors:  H Ito; N Latov
Journal:  J Neuroimmunol       Date:  1988-09       Impact factor: 3.478

10.  Motor neuron syndrome and monoclonal IgM with antibody activity against gangliosides GM1 and GD1b.

Authors:  E Nardelli; A J Steck; T Barkas; M Schluep; F Jerusalem
Journal:  Ann Neurol       Date:  1988-05       Impact factor: 10.422

View more
  4 in total

Review 1.  Monoclonal IgM autoantibody reactivity in M-IgM peripheral neuropathy.

Authors:  C Caudie
Journal:  Clin Rev Allergy Immunol       Date:  2000-08       Impact factor: 8.667

Review 2.  Specificity of antiglycolipid antibodies.

Authors:  N Baumann
Journal:  Clin Rev Allergy Immunol       Date:  2000-08       Impact factor: 8.667

Review 3.  Relationship between autoantibody specificities and peripheral nervous system involvements.

Authors:  M O Jauberteau-Marchan
Journal:  Clin Rev Allergy Immunol       Date:  2000-08       Impact factor: 8.667

4.  Cross-reactivity of anti-galactocerebroside autoantibodies with a Trypanosoma brucei proteolipidic epitope.

Authors:  M Girard; S Bisser; P Buscher; B Bouteille; J L Preud'homme; M O Jauberteau
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.